Funder
TG Therapeutics
National Cancer Institute
Takeda Pharmaceutical Company
Subject
Cancer Research,Oncology,Hematology
Reference20 articles.
1. Cancer treatment and survivorship statistics, 2016;Miller;CA Cancer J Clin,2016
2. Cancer treatment and survivorship statistics, 2012;Siegel;CA Cancer J Clin,2012
3. Second primary malignancy in bladder carcinoma - a population-based Study;Khanal;Anticancer Res,2017
4. Second primary malignancy in anal carcinoma–a us population-based study;Shah;Anticancer Res,2015
5. Molecular pathogenesis of MALT lymphoma;Troppan;Gastroenterol Res Pract,2015
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献